Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraocular Avastin versus Volon A for diabetic macular edema
2007-001553-26Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic macular edema (DME) and diabetic retinopathy (DR) comparing Intraocular Avastin with Intraocular Volon A (2 arms). Primary endpoints: Primary structural retinal outcomes at end of treatment and Primary functional retinal outcomes at end of treatment. Started Mar 2008; status: completed.
02
Drugs
bevacizumabtriamcinolone acetonide
03
Conditions
diabetic macular edema (DME)diabetic retinopathy (DR)
Beyond the preview
Go deeper on 2007-001553-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001553-26.